Case Study: NeoProteomics advances disease detection with Freeport Metrics

Neoproteomics streamlines biomarker analysis with Freeport Metrics and a single dashboard

NeoProteomics, a company providing research services for human disease detection, needed to move its platform to a cloud computing architecture and develop a new data visualization toolset to expand its product offerings. They partnered with Freeport Metrics for agile development and software architecture design services to address these challenges.

Freeport Metrics implemented a solution that optimized the platform's computation and assisted with the move to Amazon Web Services cloud computing. They also created custom data visualizations for a Java application, consolidating them into a single dashboard. This enabled NeoProteomics' scientists to more effectively analyze algorithm results, which drove the discovery of significant disease markers and helped identify new drug targets and patient stratification methods.

Neoproteomics